[Asia Economy Reporter Yoo Hyun-seok] Next Science, which operates the largest kombucha production factory in Asia, announced on the 14th that its subsidiary Freshco's leading domestic kombucha brand, ‘I'm Alive Kombucha,’ was selected as the ‘Trend Healthy Food’ of the year at the 2021 Olive Young Awards.


The ‘Olive Young Awards’ is an event where Olive Young comprehensively analyzes the sales, consumer preferences, and latest trends of products sold in its stores over the past year to select the products that received the most love from customers throughout the year.


I'm Alive Kombucha saw a rapid increase in sales this year, gaining popularity through word of mouth for its sweet and sour taste and rich refreshing sensation. It is made by fermenting carefully selected organic raw materials for an impressive 506 hours using proprietary fermentation technology. The product contains prebiotics, glucuronic acid, and minerals generated during the production process, which provide antioxidant and detox effects, help remove impurities from the body, and boost immunity, making it very popular among modern people who want to easily maintain their health.


Riding on this popularity, I'm Alive Kombucha is expanding beyond the domestic market into the global market. Its excellent quality has been proven by obtaining HACCP certification, halal certification, and a patent for its fermentation method. Following Singapore, Japan, and China, it has recently entered the Malaysian market, capturing the healthy tastes of people worldwide.



A Freshco representative said, “Thanks to the customers who trusted and loved I'm Alive Kombucha, we have been honored to be selected for the Olive Young Awards,” and added, “We will continue to faithfully reflect customer needs with world-class quality and customer-tailored marketing to become not only the best in Korea but the number one kombucha brand in the world.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing